Court Sets Dec. 1 Trial Date in NaPro vs Mylan Patent Suit
In October 2003, the court declared that Mylan Laboratories infringes certain of NaPro's patents related to stabilized formulations of paclitaxel and methods for making such stable formulations, according to NaPro.
The court also stated that the inventors listed on the NaPro patents were the first to invent the compositions and methods claimed in such patents. The...
To view the full article, register now.